Influence of the diketonato ligand on the cytotoxicities of [Ru(eta(6)-p-cymene)-(R(2)acac)(PTA)](+) complexes (PTA=1,3,5-triaza-7-phosphaadamantane)

Détails

ID Serval
serval:BIB_DA85235D88E7
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Influence of the diketonato ligand on the cytotoxicities of [Ru(eta(6)-p-cymene)-(R(2)acac)(PTA)](+) complexes (PTA=1,3,5-triaza-7-phosphaadamantane)
Périodique
European Journal of Inorganic Chemistry
Auteur⸱e⸱s
Vock  Carsten A., Renfrew  Anna K., Scopelliti.R , Lucienne.J-J , Paul J.D
ISSN
1434-1948
Statut éditorial
Publié
Date de publication
2008
Peer-reviewed
Oui
Numéro
10
Pages
1661-1671
Langue
anglais
Résumé
A series of compounds of general formula [Ru(eta(6)-p-cymene) (R(2)acac)(PTA)][X] (R(2)acac = Me(2)acac, tBu(2)acac, Ph(2)acac, Me(2)acac-Cl; PTA = 1,3,5-triaza-7-phosphaadamantane; X = BPh4, BF4), and the precursor to the Me2acac-Cl derivative [Ru(eta(6)-p-cymene)(Me(2)acac-Cl)Cl], have been prepared and characterised spectroscopically. Five of the compounds have also been characterised in the solid state by X-ray crystallography. The tetrafluoroborate salts are water-soluble, quite resistant to hydrolysis, and have been evaluated for cytotoxicity against A549 lung carcinoma and A2780 human ovarian cancer cells. The compounds are cytotoxic towards the latter cell line, and relative activities are discussed in terms of hydrolysis (less important) and lipophilicity, which appears to exert the dominating influence.
Mots-clé
bioorganometallics, anticancer drugs, metal-based drugs, ruthenium, X-ray structure, Ruthenium(Ii)-Arene Pta Complexes, Arene Complexes, Metal-Complexes, In-Vitro, Anticancer Drugs, Antitumor Drugs, Chemistry, Agents, Chemotherapy, Hydrolysis
Web of science
Création de la notice
13/10/2009 14:58
Dernière modification de la notice
20/08/2019 16:59
Données d'usage